Xinhong Chen

Xinhong Chen

Auto-generated profile, based on publicly available information

Xinhong Chen

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Nature
Verified
Journal Article
Closed access
PDF file
ABAna Badimon
Ana Badimon
HSHayley J. Strasburger
Hayley J. Strasburger
PAPinar Ayata
Pinar Ayata
XCXinhong Chen
Xinhong Chen
ANAditya Nair
Aditya Nair
ASAnne Schaefer
Anne Schaefer

22 November 2019 in Science
Verified
Journal Article
Closed access
PDF file
CSCody A. Siciliano
Cody A. Siciliano
HNHabiba Noamany
Habiba Noamany
CCChia-Jung Chang
Chia-Jung Chang
ABAlex R. Brown
Alex R. Brown
XCXinhong Chen
Xinhong Chen
KTKay M. Tye
Kay M. Tye
A brain circuit to control alcohol intake: Most people are exposed to alcohol at some point in their lives, but only a small fraction will develop a compulsive drinking disorder. Siciliano et al. first established a behavioral measure to assess how predisposition interacts with experience to produce compulsive drinking in a subset of mice (see the Perspective by Nixon and Mangieri). In search of the underlying neurobiological mechanism, they discovered that a discrete circuit between the medial prefrontal cortex and brainstem is central for the development of compulsive drinking. This circuit serves as both a biomarker for the development of compulsive drinking and a driver of its expression. It can bidirectionally control compulsive behavior by mitigating or mimicking punishment signals. Science , this issue p. 1008 ; see also p. 947

20 April 2020 in Nature Methods
Verified
Journal Article
Closed access
PDF file
SKSripriya Ravindra Kumar
Sripriya Ravindra Kumar
TMTimothy F. Miles
Timothy F. Miles
XCXinhong Chen
Xinhong Chen
DBDavid Brown
David Brown
TDTatyana Dobreva
Tatyana Dobreva
VGViviana Gradinaru
Viviana Gradinaru

10 July 2023 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
MCMiguel R. Chuapoco
Miguel R. Chuapoco
NFNicholas C. Flytzanis
Nicholas C. Flytzanis
NGNick Goeden
Nick Goeden
JOJ. Christopher Octeau
J. Christopher Octeau
KRKristina M. Roxas
Kristina M. Roxas
VGViviana Gradinaru
Viviana Gradinaru
Crossing the blood–brain barrier in primates is a major obstacle for gene delivery to the brain. Adeno-associated viruses (AAVs) promise robust, non-invasive gene delivery from the bloodstream to the brain. However, unlike in rodents, few neurotropic AAVs efficiently cross the blood–brain barrier in non-human primates. Here we report on AAV.CAP-Mac, an engineered variant identified by screening in adult marmosets and newborn macaques, which has improved delivery efficiency in the brains of multiple non-human primate species: marmoset, rhesus macaque and green monkey. CAP-Mac is neuron biased in infant Old World primates, exhibits broad tropism in adult rhesus macaques and is vasculature biased in adult marmosets. We demonstrate applications of a single, intravenous dose of CAP-Mac to deliver functional GCaMP for ex vivo calcium imaging across multiple brain areas, or a cocktail of fluorescent reporters for Brainbow-like labelling throughout the macaque brain, circumventing the need for germline manipulations in Old World primates. As such, CAP-Mac is shown to have potential for non-invasive systemic gene transfer in the brains of non-human primates.

8 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
XCXinhong Chen
Xinhong Chen
DWDamien A. Wolfe
Damien A. Wolfe
DBDhanesh Sivadasan Bindu
Dhanesh Sivadasan Bindu
MZMengying Zhang
Mengying Zhang
NTNaz Taskin
Naz Taskin
VGViviana Gradinaru
Viviana Gradinaru
Delivering genes to and across the brain vasculature efficiently and specifically across species remains a critical challenge for addressing neurological diseases. We have evolved adeno-associated virus (AAV9) capsids into vectors that transduce brain endothelial cells specifically and efficiently following systemic administration in wild-type mice with diverse genetic backgrounds, and in rats. These AAVs also exhibit superior transduction of the CNS across non-human primates (marmosets and rhesus macaques), and in ex vivo human brain slices, although the endothelial tropism is not conserved across species. The capsid modifications translate from AAV9 to other serotypes such as AAV1 and AAV-DJ, enabling serotype switching for sequential AAV administration in mice. We demonstrate that the endothelial-specific mouse capsids can be used to genetically engineer the blood-brain barrier by transforming the mouse brain vasculature into a functional biofactory. We apply this approach to Hevin knockout mice, where AAV-X1-mediated ectopic expression of the synaptogenic protein Sparcl1/Hevin in brain endothelial cells rescued synaptic deficits.

21 April 2023 in Science Advances
Verified
Journal Article
Open access
TSTimothy F. Shay
Timothy F. Shay
ESErin E. Sullivan
Erin E. Sullivan
XDXiaozhe Ding
Xiaozhe Ding
XCXinhong Chen
Xinhong Chen
SKSripriya Ravindra Kumar
Sripriya Ravindra Kumar
VGViviana Gradinaru
Viviana Gradinaru
The blood-brain barrier (BBB) presents a major challenge for delivering large molecules to study and treat the central nervous system. This is due in part to the scarcity of targets known to mediate BBB crossing. To identify novel targets, we leverage a panel of adeno-associated viruses (AAVs) previously identified through mechanism-agnostic directed evolution for improved BBB transcytosis. Screening potential cognate receptors for enhanced BBB crossing, we identify two targets: murine-restricted LY6C1 and widely conserved carbonic anhydrase IV (CA-IV). We apply AlphaFold-based in silico methods to generate capsid-receptor binding models to predict the affinity of AAVs for these identified receptors. Demonstrating how these tools can unlock target-focused engineering strategies, we create an enhanced LY6C1-binding vector, AAV-PHP.eC, that, unlike our prior PHP.eB, also works in Ly6a -deficient mouse strains such as BALB/cJ. Combined with structural insights from computational modeling, the identification of primate-conserved CA-IV enables the design of more specific and potent human brain–penetrant chemicals and biologicals, including gene delivery vectors.